Fennec Pharmaceuticals Inc. (FENC)
NASDAQ
Market Cap
$169.5M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
421 of 968
Rank in Industry
255 of 556
Largest Insider Buys in Sector
FENC Stock Price History Chart
FENC Stock Performance
About Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Insider Activity of Fennec Pharmaceuticals Inc.
Over the last 12 months, insiders at Fennec Pharmaceuticals Inc. have bought $0 and sold $3.78M worth of Fennec Pharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at Fennec Pharmaceuticals Inc. have bought $2.65M and sold $1.59M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 29,167 shares for transaction amount of $0 was made by Raykov Rosty (CHIEF EXECUTIVE OFFICER) on 2024‑04‑01.
List of Insider Buy and Sell Transactions, Fennec Pharmaceuticals Inc.
| 2024-12-02 | Sale | director | 6,409 0.0225% | $6.14 | $39,351 | +0.65% | ||
| 2024-11-04 | Sale | director | 2,431 0.0082% | $4.31 | $10,478 | +1.51% | ||
| 2024-10-08 | Sale | director | 1,406 0.0045% | $4.53 | $6,369 | +2.88% | ||
| 2024-10-01 | Sale | director | 2,431 0.0085% | $4.94 | $12,009 | -4.67% | ||
| 2024-09-04 | Sale | director | 2,431 0.0088% | $5.52 | $13,419 | -16.19% | ||
| 2024-08-01 | Sale | CHIEF EXECUTIVE OFFICER | 2,431 0.0089% | $6.25 | $15,206 | -16.59% | ||
| 2024-07-05 | Sale | director | 1,173 0.0043% | $6.03 | $7,073 | 0.00% | ||
| 2024-07-02 | Sale | CHIEF EXECUTIVE OFFICER | 2,431 0.0091% | $6.13 | $14,902 | 0.00% | ||
| 2024-06-03 | Sale | CHIEF EXECUTIVE OFFICER | 2,431 0.0089% | $6.76 | $16,434 | -17.71% | ||
| 2024-05-01 | Sale | CHIEF EXECUTIVE OFFICER | 2,431 0.009% | $9.11 | $22,152 | -36.89% | ||
| 2024-04-22 | Sale | CHIEF OPERATING OFFICER | 22,223 0.0814% | $9.32 | $207,029 | -37.26% | ||
| 2024-04-19 | Sale | CHIEF OPERATING OFFICER | 22,222 0.082% | $9.34 | $207,442 | -36.51% | ||
| 2024-04-18 | Sale | CHIEF OPERATING OFFICER | 44,444 0.1022% | $5.96 | $265,108 | -37.68% | ||
| 2024-04-17 | Sale | CHIEF OPERATING OFFICER | 44,444 0.1033% | $6.11 | $271,553 | -38.04% | ||
| 2024-04-16 | Sale | CHIEF OPERATING OFFICER | 44,444 0.1006% | $6.29 | $279,722 | -41.49% | ||
| 2024-04-15 | Sale | director | 800 0.003% | $10.45 | $8,360 | -41.67% | ||
| 2024-04-15 | Sale | CHIEF OPERATING OFFICER | 44,444 0.1001% | $6.30 | $280,126 | -41.67% | ||
| 2024-04-05 | Sale | CHIEF EXECUTIVE OFFICER | 44,300 0.1644% | $10.75 | $476,269 | -43.12% | ||
| 2024-04-04 | Sale | CHIEF EXECUTIVE OFFICER | 44,283 0.1632% | $10.89 | $482,400 | -43.72% | ||
| 2024-04-03 | Sale | CHIEF EXECUTIVE OFFICER | 40,584 0.1499% | $10.78 | $437,451 | -42.43% |
Insider Historical Profitability
97.95%
| Andrade Robert | CHIEF FINANCIAL OFFICER | 104271 0.3802% | $6.18 | 1 | 10 | |
| Raykov Rosty | director | 66432 0.2422% | $6.18 | 1 | 15 | |
| RALLIS CHRIS A | director | 52214 0.1904% | $6.18 | 0 | 12 | |
| Haigh Adrian | CHIEF OPERATING OFFICER | 0 0% | $6.18 | 0 | 6 | |
| Butts Robert W | 41504000 151.3215% | $6.18 | 1 | 0 | ||
| Southpoint Capital Advisors LP | 10 percent owner | 4077214 14.8653% | $6.18 | 3 | 1 | +14.67% |
| Essetifin SPA | 10 percent owner | 3993694 14.5608% | $6.18 | 2 | 0 | +12.47% |
| MANCHESTER MANAGEMENT CO LLC | 10 percent owner | 2017357 7.3552% | $6.18 | 42 | 0 | |
| MANCHESTER MANAGEMENT PR, LLC | 10 percent owner | 1250000 4.5574% | $6.18 | 37 | 16 | +123.37% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Southpoint Capital Advisors Lp | $45.34M | 14.92 | 4.08M | 0% | +$0 | 0.9 | |
| Sonic Gp Llc | $26.77M | 8.81 | 2.41M | 0% | +$0 | 35.88 | |
| DG Capital | $16.81M | 5.53 | 1.51M | +40.54% | +$4.85M | 10.88 | |
| Solas Capital Management Llc | $12.35M | 4.06 | 1.11M | -19.46% | -$2.98M | 7.94 | |
| The Vanguard Group | $11.27M | 3.71 | 1.01M | -11.09% | -$1.41M | <0.0001 | |
| BlackRock | $10.31M | 3.39 | 927,466 | -0.76% | -$79,230.00 | <0.0001 | |
| Aigh Capital Management Llc | $6.34M | 2.09 | 570,332 | +73.16% | +$2.68M | 3.63 | |
| HARBERT FUND ADVISORS, INC. | $5.19M | 1.71 | 466,869 | 0% | +$0 | 3.77 | |
| State Street | $3.38M | 1.11 | 303,519 | +14.26% | +$421,103.24 | <0.0001 | |
| Geode Capital Management | $2.44M | 0.8 | 219,754 | +0.53% | +$12,943.68 | <0.0001 | |
| Lion Point Capital LP | $1.89M | 0.62 | 170,000 | +54.55% | +$667,200.00 | 3.66 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1.6M | 0.53 | 144,218 | New | +$1.6M | 0.32 | |
| Renaissance Technologies | $1.56M | 0.51 | 139,900 | New | +$1.56M | <0.01 | |
| Northern Trust | $1.27M | 0.42 | 114,068 | +2.06% | +$25,664.96 | <0.0001 | |
| Morgan Stanley | $823,880.00 | 0.27 | 74,090 | -3.95% | -$33,904.85 | <0.0001 | |
| CIBC World Markets | $779,000.00 | 0.26 | 70,065 | -2.64% | -$21,124.67 | <0.01 | |
| Millennium Management LLC | $650,898.00 | 0.21 | 58,534 | +307.36% | +$491,114.74 | <0.0001 | |
| Legato Capital Management Llc | $635,186.00 | 0.21 | 57,121 | New | +$635,186.00 | 0.08 | |
| Citadel Advisors LLC | $541,700.00 | 0.18 | 48,714 | New | +$541,700.00 | <0.0001 | |
| BNY Mellon | $535,112.00 | 0.18 | 48,122 | +4.63% | +$23,674.28 | <0.0001 | |
| 683 Capital Management Llc | $534,961.00 | 0.18 | 48,108 | -65.64% | -$1.02M | 0.06 | |
| Hartford Financial Management Inc | $531,514.00 | 0.18 | 47,798 | +0.95% | +$5,004.00 | 0.13 | |
| Goldman Sachs | $479,172.00 | 0.16 | 43,091 | +39% | +$134,451.94 | <0.0001 | |
| Charles Schwab | $461,447.00 | 0.15 | 41,497 | 0% | +$0 | <0.0001 | |
| Arrowstreet Capital, Limited Partnership | $444,000.00 | 0.15 | 39,909 | New | +$444,000.00 | <0.0001 | |
| Eudaimonia Advisors Llc | $393,192.00 | 0.13 | 35,359 | +8.18% | +$29,723.75 | 0.22 | |
| Russell Investments Group Ltd | $380,971.00 | 0.13 | 34,260 | +71,275% | +$380,437.24 | <0.01 | |
| Squarepoint Ops LLC | $374,677.00 | 0.12 | 33,694 | New | +$374,677.00 | <0.01 | |
| UBS | $329,352.00 | 0.11 | 29,618 | +48.32% | +$107,296.83 | <0.0001 | |
| Wexford Capital, LLC | $293,724.00 | 0.1 | 26,414 | 0% | +$0 | 0.06 | |
| Nuveen | $289,187.00 | 0.1 | 26,006 | +6.32% | +$17,180.42 | <0.0001 | |
| Susquehanna International Group | $251,301.00 | 0.08 | 22,599 | +50.26% | +$84,056.12 | <0.0001 | |
| RhumbLine Advisers | $223,758.00 | 0.07 | 20,123 | +1.21% | +$2,668.68 | <0.0001 | |
| Jump Financial Llc | $211,280.00 | 0.07 | 19,000 | +34.75% | +$54,488.00 | <0.01 | |
| Bank of America | $183,246.00 | 0.06 | 16,479 | -58.86% | -$262,164.43 | <0.0001 | |
| Jane Street Capital | $172,961.00 | 0.06 | 15,554 | New | +$172,961.00 | <0.0001 | |
| Barclays | $143,000.00 | 0.05 | 12,876 | -48.65% | -$135,481.28 | <0.0001 | |
| Deutsche Bank | $136,921.00 | 0.05 | 12,313 | +8.86% | +$11,142.28 | <0.0001 | |
| Worth Venture Partners | $114,836.00 | 0.04 | 10,327 | -92.7% | -$1.46M | 0.23 | |
| Cubist Systematic Strategies | $112,999.00 | 0.04 | 10,162 | New | +$112,999.00 | <0.01 | |
| New York State Common Retirement Fund | $108,000.00 | 0.04 | 9,752 | -8% | -$9,391.30 | <0.0001 | |
| JPMorgan Chase | $109,232.00 | 0.04 | 9,823 | -25.01% | -$36,429.20 | <0.0001 | |
| MetLife Investment Management | $107,630.00 | 0.04 | 9,679 | 0% | +$0 | <0.01 | |
| American International Group | $99,457.00 | 0.03 | 8,944 | -0.84% | -$845.12 | <0.0001 | |
| Qube Research & Technologies | $98,790.00 | 0.03 | 8,884 | New | +$98,790.00 | <0.0001 | |
| Wells Fargo | $66,931.00 | 0.02 | 6,019 | +15.22% | +$8,840.36 | <0.0001 | |
| Fidelity Investments | $56,191.00 | 0.02 | 5,053 | +0.48% | +$266.89 | <0.0001 | |
| Citigroup | $52,321.00 | 0.02 | 4,691 | +73.93% | +$22,240.05 | <0.0001 | |
| State Of Wyoming | $23,085.00 | 0.01 | 2,076 | -16.29% | -$4,492.46 | <0.01 | |
| CalSTRS | $20,294.00 | 0.01 | 1,825 | -38.9% | -$12,921.44 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.